Veradigm (NASDAQ:MDRX) Now Covered by StockNews.com

Equities research analysts at StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX) in a research report issued to clients and investors on Wednesday. The firm set a “hold” rating on the software maker’s stock.

Veradigm Price Performance

Shares of Veradigm stock opened at $9.00 on Wednesday. The company’s fifty day moving average price is $9.58 and its two-hundred day moving average price is $9.06. Veradigm has a 52-week low of $5.01 and a 52-week high of $13.69.

Institutional Investors Weigh In On Veradigm

A number of institutional investors have recently added to or reduced their stakes in the stock. Innealta Capital LLC bought a new position in shares of Veradigm during the 2nd quarter worth approximately $38,000. Meadow Creek Wealth Advisors LLC bought a new position in shares of Veradigm during the first quarter valued at $83,000. Tyro Capital Management LLC acquired a new stake in shares of Veradigm in the 1st quarter valued at $9,055,000. Goldman Sachs Group Inc. grew its holdings in shares of Veradigm by 6.6% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,596,684 shares of the software maker’s stock worth $16,749,000 after purchasing an additional 99,528 shares during the last quarter. Finally, Wellington Management Group LLP increased its position in shares of Veradigm by 117.8% during the 4th quarter. Wellington Management Group LLP now owns 5,806,297 shares of the software maker’s stock worth $60,908,000 after purchasing an additional 3,140,483 shares in the last quarter.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.